2,333
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, computational studies, tyrosinase inhibitory kinetics and antimelanogenic activity of hydroxy substituted 2-[(4-acetylphenyl)amino]-2-oxoethyl derivatives

, , , , , , , , , , , & show all
Pages 1562-1572 | Received 23 May 2019, Accepted 06 Aug 2019, Published online: 28 Aug 2019

References

  • Bonaventure J, Domingues MJ, Larue L. Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells. Pigment Cell Melanoma Res 2013;26:316–25.
  • Borovansky J, Riley PA, editors. Melanins and melanosomes: biosynthesis, structure. Physiological and pathological functions. New York: John Wiley & Sons; 2011.
  • Lei TC, Virador V, Yasumoto KI, et al. Stimulation of melanoblast pigmentation by 8-methoxypsoralen: the involvement of microphthalmia-associated transcription factor, the protein kinase a signal pathway, and proteasome-mediated degradation. J Invest Dermatol 2002;119:1341–9.
  • Sviderskaya EV, Hill SP, Balachandar D, et al. Agouti signaling protein and other factors modulating differentiation and proliferation of immortal melanoblasts. Dev Dynamics 2001;221:373–9.
  • Seiberg M. Keratinocyte–melanocyte interactions during melanosome transfer. Pigment Cell Res 2001;14:236–42.
  • Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature 2007;445:843.
  • Delevoye C. Melanin transfer: the keratinocytes are more than gluttons. J Invest Dermatol 2014;134:877–9.
  • Meredith P, Riesz J. Radiative relaxation quantum yields for synthetic eumelanin. Photochem Photobiol 2004;79:211–6.
  • Vandamme M, Robert E, Pesnel S, et al. Antitumor effect of plasma treatment on U87 gliomaxenografts: preliminary results. Plasma Process Polym 2010;7:264–73.
  • Brożyna AA, Jóźwicki W, Carlson JA, Slominski AT. Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma. Hum Pathol 2013;44:2071–4.
  • Slominski A, Paus RA, Mihm MC. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res 1998;18:3709–15.
  • Brożyna AA, Jóźwicki W, Roszkowski K, et al. Melanin content in melanoma metastases affects the outcome of radiotherapy. Oncotarget 2016;7:17844.
  • Videira IF, Moura DF, Magina S. Mechanisms regulating melanogenesis. An Bras Dermatol 2013;88:76–83.
  • Cooksey CJ, Garratt PJ, Land EJ, et al. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J Biol Chem 1997;272:26226–35.
  • Hearing VJ, Jiménez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 1989;2:75–85.
  • Fairhead M, Thöny-Meyer L. Bacterial tyrosinases: old enzymes with new relevance to biotechnology. New Biotechnol 2012;29:183–91.
  • Büyükokuroğlu ME, Gülçin I, Oktay M, Küfrevioğlu OI. In vitro antioxidant properties of dantrolene sodium. Pharmacol Res 2001;44:491–4.
  • Shahidi F, Janitha PK, Wanasundara PD. Phenolic antioxidants. Crit Rev Food Sci Nutr 1992;32:67–103.
  • Gülçin İ, Oktay M, Küfrevioğlu Öİ, Aslan A. Determination of antioxidant activity of lichen Cetraria islandica (L) Ach. J Ethnopharmacol 2002;79:325–9.
  • Yasui H, Sakurai H. Age-dependent generation of reactive oxygen species in the skin of live hairless rats exposed to UVA light . Exp Dermatol 2003;12:655–61.
  • Ito N, Hirose M, Fukushima S, et al. Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis. Food Chem Toxicol 1986;24:1071–82.
  • Ashraf Z, Rasool R, Hassan M, et al. Synthesis, bioevaluation and molecular dynamic simulation studies of dexibuprofen–antioxidant mutual prodrugs. Int J Mol Sci 2016;17:2151.
  • (a) Larik FA, Saeed A, Channar PA, et al. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers. Eur J Med Chem 2017;141:273.; (b) Saeed A, Ali Mahesar P, Ali Channar P, et al. Synthesis, Molecular docking studies of Coumarinyl-pyrazolinyl substituted thiazoles as non-competitiveinhibitors of mushroom tyrosinase. Bioorg Chem 2017;74:187.
  • Ashooriha M, Khoshneviszadeh M, Khoshneviszadeh M, et al. 1,2,3-Triazole-based kojic acid analogs as potent tyrosinase inhibitors: design, synthesis and biological evaluation. Bioorg Chem 2019;82:414–22.
  • Menezes JCJMDS, Kamat SP, Cavaleiro JAS, et al. Synthesis and antioxidant activity of long chain alkyl hydroxycinnamates. Eur J Med Chem 2011;46:773–7.
  • Miliovsky M, Svinyarov I, Mitrev Y, et al. A novel one-pot synthesis and preliminary biological activity evaluation of cis-restricted polyhydroxy stilbenes incorporating protocatechuic acid and cinnamic acid fragments. Eur J Med Chem 2013;66:185–92.
  • Ashraf Z, Rafiq M, Seo S-Y, et al. Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase. Bioorg Med Chem 2015;23:5870–80.
  • Ashraf Z, Rafiq M, Seo S-Y, et al. Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase. Eur J Med Chem 2015;98:203–11.
  • Chen Z, Cai D, Mou D, et al. Design, synthesis and biological evaluation of hydroxy-or methoxy-substituted 5-benzylidene (thio) barbiturates as novel tyrosinase inhibitors. Bioorg Med Chem 2014;22:3279–84.
  • Huang HC, Chang TY, Chang LZ, et al. Inhibition of melanogenesis versus antioxidant properties of essential oil extracted from leaves of Vitex negundo Linn and chemical composition analysis by GC-MS. Molecules 2012;17:3902–16.
  • Lee J, Jung E, Park J, et al. Glycyrrhizin induces melanogenesis by elevating a cAMP level in B16 melanoma cells. J Invest Dermatol 2005;124:405–11.
  • Kim A, Yang Y, Lee MS, et al. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression. Pigment Cell Melanoma Res 2008;21:653–64.
  • Hamid MA, Sarmidi MR, Park CS. Mangosteen leaf extract increases melanogenesis in B16F1 melanoma cells by stimulating tyrosinase activity in vitro and by up-regulating tyrosinase gene sinase gene expression. Int J Mol Med 2012;29:209–17.
  • Jung GD, Yang JY, Song ES, Park JW. Stimulation of melanogenesis by glycyrrhizin in B16 melanoma cells. Exp Mol Med 2001;33:131.
  • Kadam RU, Roy N. Recent trends in drug-likeness prediction: a comprehensive review of in silico methods. Indian J Pharm Sci 2007;69:609.
  • Tian S, Wang J, Li Y, et al. The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Deliv Rev 2015;86:2–10.
  • Chen WC, Tseng TS, Hsiao NW, et al. Discovery of highly potent tyrosinase inhibitor, T1, with significant anti-melanogenesis ability by zebrafish in vivo assay and computational molecular modeling. Sci Rep 2015;5:7995.
  • Ashraf Z, Rafiq M, Nadeem H, et al. Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies. PLoS One 2017;12:e0178069.
  • Ashraf Z, Rafiq M, Seo SY, et al. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors. J Enzyme Inhib Med Chem 2015;30:874–83.
  • Wang Q, Qiu L, Chen XR, et al. Inhibitory effects of phloridzin dihydrate on the activity of mushroom (Agaricus bisporus) tyrosinase. Bioorg Med Chem 2007;15:1568–71.
  • Chiari ME, Vera DM, Palacios SM, Carpinella MC. Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from Daleaelegans. Bioorg Med Chem 2011;19:3474–82.
  • Rafiq M, Saleem M, Hanif M, et al. Synthesis, structural elucidation and bioevaluation of 4-amino-1, 2, 4-triazole-3-thione’s Schiff base derivatives. Arch Pharmacal Res 2016;39:161–71.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
  • Chung KW, Park YJ, Choi YJ, et al. Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2, 4 dihydroxybenzylidene) pyrrolidine-2, 5-dione (3-DBP). Biochim Biophys Acta (BBA)–General Subjects 2012;1820:962–9.
  • Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–12.
  • Lovell SC, Davis IW, Arendall WB, et al. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 2003;50:437–50.
  • Chen VB, Arendall WB, Headd JJ, et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallograph Sect D: Biol Crystallogr 2010;66:12–21.
  • Pramanik S, Roy K. Exploring QSTR modeling and toxicophore mapping for identification of important molecular features contributing to the chemical toxicity in Escherichia coli. Toxicol In Vitro 2014;28:265–72.
  • Willard L, Ranjan A, Zhang H, et al. VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 2003;31:3316–9.
  • Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Meth mol biol. 2015;1263:243–50.